Date: Monday 11 Oct 2010
Drugs companies AstraZeneca and Pozen said their jointly developed pain reliever Vimovo has received positive agreement for approval across 23 EU countries.
No recent information was found.
No recent information was found.
No recent information was found.
| Currency | US Dollars |
| Share Price | $ 6.94 |
| Change Today | $ -0.24 |
| % Change | -3.34 % |
| 52 Week High | $7.91 |
| 52 Week Low | $2.26 |
| Volume | 234,466 |
| Shares Issued | 29.92m |
| Market Cap | $207.61m |
| Beta | 1.26 |
| RiskGrade | 326 |
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 2 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| Time | Volume / Share Price |
| 16:00 | 17,282 @ $6.94 |
| 15:59 | 100 @ $6.94 |
| 15:59 | 100 @ $6.94 |
| 15:59 | 200 @ $6.93 |
| 15:59 | 100 @ $6.94 |
You are here: research